DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

51.56 -0.27 (-0.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AZN $51.56 -0.52%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.39
Previous Close $51.83
Daily Range $51.33 - $51.69
52-Week Range $39.72 - $52.27
Market Cap $64.5B
P/E Ratio 10.39
Dividend (Yield) $3.80 (5.4%)
Ex-Dividend Date
Dividend Pay Date
02/13/13
03/18/13
Volume 2,737,021
Average Daily Volume 1,862,500
Current FY EPS $5.30

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

Cheerleaders: Look Beyond Pharma For Jobs

Good News for Roche's Tarceva - Analyst Blog

Good News for Roche's Tarceva - Analyst Blog

Is AstraZeneca Gearing Up for a Shopping Spree?

With the company's pipeline in turmoil, AstraZeneca looks into the acquisition game.

Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock

A Closer Look at AstraZeneca's Dividend Potential

Is AstraZeneca a solid pick for dividend growth?

What To Buy And Sell In Your High-Yield Portfolio

Big Pharma's Biggest Losers

A Fool recaps first quarter earnings fumbles around the pharmaceutical industry.

Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?

Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?

Tackling Cancer: Endometrial Cancer's Biggest Current and Upcoming Players

Cancer research is big business, and it pays to know where research dollars are headed.

See More AZN News...

AZN's Top Competitors

AZN $51.56 (-0.52%)
Current stock: AZN
JNJ $88.09 (0.73%)
Current stock: JNJ
NVS $74.15 (-1.15%)
Current stock: NVS
RHHBY $63.13 (-0.96%)
Current stock: RHHBY